Kingworld Medicines Group Limited

1110

KYG5268M1006

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-05-14 am EDT			5-day change	1st Jan Change
0.58 ^HKD	+3.57%		+9.43%	-7.94%

Apr. 23	Kingworld Medicines Posts 68% Jump in 2023 Profit	MT
Mar. 27	Kingworld Medicines Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024	CI

Kingworld Medicines Group Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 30 June 2023

March 30, 2023 at 10:45 am EDT

Kingworld Medicines Group Limited proposed ordinary final dividend of HKD 0.0247 per share for the year ended 31 December 2022. Date of shareholders' approval is 29 May 2023; Ex-dividend date is 01 June 2023; Record date is 08 June 2023; Payment date is 30 June 2023.

Latest news about Kingworld Medicines Group Limited

Kingworld Medicines Posts 68% Jump in 2023 Profit	Apr. 22	MT
Kingworld Medicines Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024	Mar. 27	CI
Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Kingworld Medicine Expects Up to 75% Profit Jump in 2023; Shares Up 6%	Mar. 21	MT
Kingworld Medicines Group Limited Provides consolidated Earnings Guidance for the Year Ended 31 December 2023	Mar. 20	CI
Kingworld Medicines Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Kingworld Medicines Subsidiary Buys Shares in Taiko Pharmaceutical	23-08-15	MT
Kingworld Medicines Group Expects Up to 40% Rise in H1 Profit	23-08-02	MT
Kingworld Medicines Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023	23-08-02	CI
Kingworld Medicines Group Limited Approves Final Dividend for the Year Ended 31 December 2022	23-05-29	CI
Kingworld Medicines to Invest 832 Million Yen in Taiko Pharmaceutical	23-04-25	MT
Kingworld Medicines to Grant 3.5 Million Awarded Shares Under 2019 Scheme	23-04-07	MT
Kingworld Medicines Group Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 30 June 2023	23-03-30	CI
Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
KIngworld Medicines Group Acquires 60% Stake in Innopharm	22-10-16	MT
Kingworld Medicines Completes Topping Out Process of Longde Health Industrial Park	22-10-10	MT
Kingworld's H1 Profit Jumps	22-09-14	MT
Kingworld Medicines Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31	CI
Kingworld Medicines Group Forecasts Up To 25% Rise in H1 Net Profit	22-08-11	MT
Kingworld Medicines Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2022	22-08-10	CI
Kingworld Medicines Group Limited Announces Final Cash Dividend for the Financial Year Ended 31 December 2021, Payable on 30 June 2022	22-05-27	CI
Kingworld Medicines Group Limited Proposes Final Dividend for the Year Ended 31 December 2021, Payable on 30 June 2022	22-03-29	CI
Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-29	CI
Kingworld Medicines Sees up to 160% Surge in 2021 Profit	22-03-23	MT
Kingworld Medicines Group Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2021	22-03-23	CI

Chart Kingworld Medicines Group Limited

Duration

Period

More charts

Company Profile

Kingworld Medicines Group Limited is an investment holding company principally engaged in the distribution and sales of pharmaceutical and healthcare products. The Companyâs products include cough and phlegm relieving, gastrointestinal, vitamin, orthopedics, cardiovascular, influenza and others. The Company operates through two business segments. The Distribution Sales of Pharmaceutical and Healthcare Products segment is engaged in the distribution and sales of branded imported pharmaceutical and healthcare products primarily in Hong Kong and the Peopleâs Republic of China (PRC). The Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices segment is engaged in the manufacture and sales of electrotherapeutic and physiotherapeutic devices, as well as general medical examination devices in the PRC.

Sector

Pharmaceuticals

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
KINGWORLD MEDICINES GROUP LIMITED	-7.94%	43.98M
MCKESSON CORPORATION	+18.99%	71.7B
CARDINAL HEALTH, INC.	-3.46%	23.73B
SINOPHARM GROUP CO. LTD.	+10.27%	9.01B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+11.24%	8.72B
HUADONG MEDICINE CO., LTD	-18.91%	8.29B
H. LUNDBECK A/S	+16.00%	5B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.83%	4.48B
EBOS GROUP LIMITED	-2.11%	4.08B
GALENICA AG	-1.72%	3.92B

Pharmaceuticals Wholesale